MUMBAI: Indian authorities on Wednesday halted production at a pharmaceutical factory under investigation over the deaths of 66 children in The Gambia, according to local media.

The World Health Organisation last week warned that four cough and cold remedies manufactured by Maiden Pharmaceuticals in the northern state of Haryana could cause acute kidney injury.

Laboratory testing found “unacceptable amounts” of potentially life-threatening contaminants, the WHO said, adding that the products may have been distributed beyond the West African country.

“We have ordered that all drug production at this unit be stopped with immediate effect,” Haryana state health minister Anil Vij was quoted as telling Indian news agency PTI on Wednesday.

The minister added that a preliminary inspection found 12 violations at Maiden’s facility in the town of Kundli, about 40 kilometres from the capital New Delhi.

Maiden Pharmaceuticals director Naresh Goyal has reportedly denied the deaths were caused by cough syrups produced at his company.

“The deaths have been due to paracetamol syrup and not due to our cough syrups,” he told India’s Economic Times newspaper. Police in The Gambia on Saturday said they were launching their own investigation into the children’s deaths.

Published in Dawn, October 13th, 2022

Opinion

Editorial

China security ties
Updated 14 Nov, 2024

China security ties

If China's security concerns aren't addressed satisfactorily, it may affect bilateral ties. CT cooperation should be pursued instead of having foreign forces here.
Steep price
14 Nov, 2024

Steep price

THE Hindu Kush-Himalayan region is in big trouble. A new study unveiled at the ongoing COP29 reveals that if high...
A high-cost plan
14 Nov, 2024

A high-cost plan

THE government has approved an expensive plan for FBR in the hope of tackling its deep-seated inefficiencies. The...
United stance
Updated 13 Nov, 2024

United stance

It would've been better if the OIC-Arab League summit had announced practical measures to punish Israel.
Unscheduled visit
13 Nov, 2024

Unscheduled visit

Unusual IMF visit shows the lender will closely watch implementation of programme goals to prevent it from derailing.
Bara’s businesswomen
13 Nov, 2024

Bara’s businesswomen

Bara’s brave women have proven that with the right support, societal barriers can be overcome.